November 9, 2011

Wilshire Grand Hotel in Los Angeles, CA

Sponsorship and Exhibit Opportunities Available

7:30 am

Registration & Breakfast

8:15 am

Introductions and Acknowledgment of Sponsors

Platinum
Gold
Silver
Bronze

8:30 am

Morning Keynote Presentation 

Sponsored by

"The Competitiveness of the Greater Los Angeles ' Bioscience Industry Cluster," by Mitch Horowitz, PhD, Vice President & Managing Director, Battelle Technology Partnership Practice

Dr Horowitz will examine recent trends on the competitiveness of the Greater Los Angeles/Orange County Bioscience Industry Cluster, through the recession in terms of industry growth and venture capital as well as putting into context the broader market drivers for biosciences development and the rise of global competition and its implications. This presentation will examine best practices in growing biosciences industry cluster and involve a discussion on the preparedness of the Greater Los Angeles region to advance its biosciences industry cluster. 

9:30 am

Break

Emerging Company Presentations

Sierra Room

Los Angeles Room

Garden East

Garden West

  9:45 am

MannKind Oncology  Company 

(Cancer therapeutics)

Lone Star Heart, Inc. 

(Therapies to preserve and restore adequate heart function in patients with congestive heart failure)

CapWave 

(Rapid, sensitive, and portable ELISA platform for use anywhere antibody based testing can be done)

Avita Medical  (Regenerative medicine for wound healing) 

 10:00 am

Cold Genesys 

(A novel therapy to target bladder cancer cells)

ClaremontBIO 

(Devices for lysis and nucleic acid extraction from microbial cells for PCR ready sample)

Kythera Biopharma 

(Novel prescription products for the aesthetic market) 

 10:15 am

Neumedicines

 (Protein therapeutics for applications in oncology, hematology, and immunology)  

Otokinetics 

(Implantable hearing aids)

Maven Biotech 

(Developing LFIRE™ - a flexible, cost-effective, high density imaging technology for the multiplexed, quantitative, label-free, real-time characterization of biomarker binding reactions)

Aptitude Medical Systems
Technology to accelerate molecular diagnostics by discovering and providing high performance aptamers

 10:30 am

Paganini Biopharma

 (Novel monoclonal antibody treatment for triple negative breast cancer)

Jet Lasik 

(A device combining a modified collagen-coated contact lens with a layer of live cultured skin cells to act as a postoperative tissue transplant "bandage" in photorefractive keratectomy procedures) 

Integrated Plasmonics

 (Nano photonics research to develop a point-of-care device for low-cost, disposable, multiplexed, and label-free diagnostics) 

NanoVega
Technology for imaging and targeting circulating cancer cells

10:45 am

Break

11:00 am

Bioniz

 (Therapeutics for autoimmune diseases based on novel peptides which selectively inhibit multiple cytokines without compromising the rest of the immune system)

MiniPumps

(small, low-cost, and accurate pumps for subcutaneous drug delivery)

DxTerity Diagnostics

 (Developing its patented NEAT™ platform to provide a pathway to incorporate genetic testing into routine medical care) 

OlFactor Laboratories 

(Novel masking agents to protect animals and humans from vector borne diseases)

 11:15 am

Allegro Ophthalmic (Integrin peptide therapy for retinal vascular diseases, including  wet age-related macular  degeneration and diabetic macular edema

BioPhotas 

(Light therapy devices for the treatment of dermatological and muscular/skeletal conditions)

NanoTech Biomachines
Lab-on-a-chip technology for fast, multiplexing, high-throughput detection, and quantification of biological analytes

Acelot 

(A cheminformatics company offering products and services for the pharmaceutical industry)

11:30 am

ImmunGene

 (Monoclonal antibody-based therapeutics to treat cancer, autoimmune disorders and other diseases)

NanoPulse 

(Medical devices to treat a broad array of commonly encountered skin lesions)

Eye Predict 

(Assessing brain disorders with gaze measures)

SMRT Therapeutics 

(Small molecules for treating genetic diseases) 

 11:45 am

ImmunoCellular Therapeutics (Immuno-therapeutics for brain cancer)

Viderics 

(Inexpensive, handheld diagnostic ultrasound devices)

Ikona Medical

(Image probe for diagnostic assessment of women suffering from abnormal uterine bleeding.

Vascular Access Systems 

(Automated device allowing researchers to more efficiently make injections in mice through their tails)

 12:00 noon

TheraBiologics 

(A proprietary stem cell platform for targeted therapeutic delivery to cancer cells)

Quantason LLC 

(Bi-modal functional Ultrasound platform for breast cancer screening and diagnosis)

Reflectance Medical 

(Physiologic sensor to enable physicians to quickly assess a patient's metabolic status)

Sira Technologies 

(Cold chain temperature management solutions for food, pharmaceuticals, and other perishables)

12:15 pm

Lunch & Keynote Presentations 

Sponsored by

1:00 pm

"Canada-California: A Partnership for Innovation and Economic Growth," By David Fransen, Consul General of Canada in Los Angeles

1:30 pm

"Breakthrough Cancer Coalition for FDA Reform," by Jonathan Lasch, PhD, Director, AMI - USC

1:40 pm

"Creating Entrepreneurial Universities to Fuel Regional Economic Growth," by Kalyanam Shivkumar MD, PhD, Professor of Medicine & Radiology and Director, UCLA Cardiac Arrhythmia Center & EP Programs, UCLA Health System

Break

Breakout Sessions: Resources for Entrepreneurs

Break

 Workshop on Securing SBIR & STTR Grant Funding for your Emerging Bioscience Company 

Sponsored by
 

Dr Greg Milman from the NIH and David Hood of DH3 Consulting will lead this workshop which will:

·          Provide updates on funding opportunities from both the NIH and DoD

·          Sharpen your grant-writing skills and

·          Teach you how to tap various government funding opportunities.

Closing Reception and Poster Display 

Sponsored by  

Conference Adjourns